APA (7th ed.) Citation

SF, K., A, B., M, L., S, B., B, P., G, V., . . . N, R. (2019). Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression. Clinical genitourinary cancer, 17(3), 169. https://doi.org/10.1016/j.clgc.2019.01.014

Chicago Style (17th ed.) Citation

SF, Kammerer-Jacquet, et al. "Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression." Clinical Genitourinary Cancer 17, no. 3 (2019): 169. https://doi.org/10.1016/j.clgc.2019.01.014.

MLA (9th ed.) Citation

SF, Kammerer-Jacquet, et al. "Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression." Clinical Genitourinary Cancer, vol. 17, no. 3, 2019, p. 169, https://doi.org/10.1016/j.clgc.2019.01.014.